fbpx

OHF

Oxalosis & Hyperoxaluria Foundation

International Hyperoxaluria Workshop

Hermitage Hotel Prague, Prague, Czech Republic
26 - 27 June 2026



Professional Workshop

The International Hyperoxaluria Workshop is recognized globally as the largest professional event in which leading stakeholders come together to explore clinical advances, cultural trends, and current research outcomes that will inform our work and provide better care to those facing the challenges of hyperoxaluria diseases.

Collaboratively, leading experts, researchers, clinicians, and members of industry will engage each other through inspiring dialogue aiming to advance the highest quality and development of hyperoxaluria future outcomes.

All conference registrations will include full access to the 2-day scientific program, access to the poster exhibition and networking events.

GENERAL INFO

DESTINATION
VENUE

WORKSHOP AGENDA

COMING SOON:

The workshop agenda is currently to be confirmed and will be shared with all participants once it has been finalized.

CONTACTS

CONTACT US

REGISTRATION

REGISTRATION GUIDELINES
REGISTER NOW

ABSTRACT SUBMISSION

SUBMISSION GUIDELINES
SUBMIT ABSTRACT NOW
TRAVEL GRANTS

ACCOMMODATION

BOOK HOTEL

Key Dates

  • Abstract Submission Deadline: 1 April 2026
  • Travel Grant Application Deadline: 15 April 2026
  • Notification Letters for the Authors: 15 April 2026
  • Accommodation Booking Deadline: 20 April 2026
  • Standard Registration Deadline: 13 May 2026

Workshop Leadership

Conference Directors

Yaacov Frishberg, MD
Shaare Zedek Medical Center
Jerusalem, Israel

Kyle Wood, MD
University of Alabama Medicine 
Birmingham, Alabama, USA
 

Steering Committee

Nicola Brunetti Pierri, MD
University of Naples
Naples, Italy

Monica Diaz-Gavilan, PhD
University of Granada
Granada, Spain

Sonia Fargue, MD, PhD
University of Alabama at Birmingham
Birmingham, Alabama, USA

Ita Pfeferman Heilberg, M.D., PhD.
Federal University of São Paulo
Sao Paulo, Brazil

Mathieu Lemaire, MSc MDCM PhD FRCP(C)
The Hospital for Sick Children
University of Toronto
Toronto, Canada

Mini Michael, MD, FRACP, FASN, MMed
Texas Children’s Hospital
Houston, Texas, USA

Shabbir Moochhala, MBChB, PhD, FRCPE
Royal Free Hospital
London, UK

Eduardo Salido, MD, PhD
University Hospital of Canary Islands
Tenerife, Spain

Neveen Soliman, MD, PhD
Cairo University
Cairo, Egypt

Bhaskar Somani, MRCS, FEBU, FRCS
University Hospital Southampton
Southampton, UK

Velibor Tasic, MD, PhD, FESPN
University Children’s Hospital
Skopje, Macedonia

Jakub Zieg, MD, PhD
University Motol Hospital
Prague, Czech Republic

Conference Directors

Yaacov Frishberg, MD
Shaare Zedek Medical Center
Jerusalem, Israel 		Kyle D. Wood, MD
University of Alabama at Birmingham
Birmingham, Alabama
Steering Committee
Yaacov Frishberg, M.D.
Shaare Zedek Medical Center
Jerusalem, Israel		 Jaap Groothoff, M.D.
Emma Children’s Hospital
Amsterdam, Netherlands		 Peter C. Harris, Ph.D.
Mayo Clinic
Rochester, MN, United States		 Felix Knauf, M.D.
Charité – University Medicine
Berlin, Germany
John Knight, Ph.D.
University of Alabama at Birmingham
Birmingham, AL, United States		 W. Todd Lowther, Ph.D.
Wake Forest School of Medicine Winston-Salem, NC, United States		 Shabbir Moochhala, M.D.
Royal Free Hospital
London, United Kingdom		 Lama Nazzal, M.D., MSc.
New York University
New York, NY, United States
Gregory Tasian, M.D., MSc, MSCE
The Children’s Hospital of Philadelphia
Philadelphia, PA, United States		 Jonathan Whittamore, Ph.D.
University of Texas Southwestern
Dallas, TX, United States

Call for Abstracts

The scientific committee of the 15th International Hyperoxaluria Workshop invites all to submit an abstract on the following program topics. Each session will be comprised of clinical updates, major challenges, and a research update. There is a 300-word limit.

Submit an Abstract
 
Key Topics:
  • Oxalate Metabolism
  • Oxalate-Induced Disease Outside the Kidneys
  • PH3 – The Most Prevalent and Mysterious Form of PH
  • Current Treatment of PH1
  • Future Therapeutic Approaches for PH
  • Extra-Hepatic Oxalate Production
  • Making PH Care Work in Resource-Poor Settings
  • Enteric Hyperoxaluria
  • Urology
  • Hyperoxaluria Registries / Centers

Deadline for general abstract submission April 1st, 2026 and notifications will be received by April 15th, 2026.

5

Young Investigator Travel Grants

For purposes of the travel grant program, those who will be eligible to apply are early-stage investigators still in degree program (Ph.D, M.D. or equivalent), or within 5 years of completing a graduate or clinical training program. Grants are available for presenting or corresponding authors. There are a limited number of travel awards (may be used for registration fee if needed). 
 
Travel Grant

Sponsorship

Your sponsorship helps us to empower and educate patients, advocates, and hyperoxaluria disease stakeholders to help them drive progress and create positive change. The International Hyperoxaluria Workshop offers many unique opportunities to support the OHF community by participating in the largest think tank event for the Hyperoxaluria community. We welcome the support of our sponsors and partners in raising awareness and helping to equip patients, advocates, physicians, and researchers with information, tools, and insights that will prepare them for the road ahead.

 
Your Support Will:
  • Drive research
  • Promote innovation
  • Lead to breakthroughs
  • Change lives

If you are interested in sponsoring the workshop, or would like more information, please contact Julie Bertarelli at julieb@ohf.org.

Workshop Sponsors

Champion Level

Alnylam

Alnylam has funded the scientific, medical, and educational part of the meeting only.

Friend Level